ZA937244B - Use of IL-10 to prevent or treat insulin-dependentdiabetes mellitus - Google Patents

Use of IL-10 to prevent or treat insulin-dependentdiabetes mellitus

Info

Publication number
ZA937244B
ZA937244B ZA937244A ZA937244A ZA937244B ZA 937244 B ZA937244 B ZA 937244B ZA 937244 A ZA937244 A ZA 937244A ZA 937244 A ZA937244 A ZA 937244A ZA 937244 B ZA937244 B ZA 937244B
Authority
ZA
South Africa
Prior art keywords
prevent
treat insulin
mellitus
dependentdiabetes
dependentdiabetes mellitus
Prior art date
Application number
ZA937244A
Other languages
English (en)
Inventor
Martha W Bond
Kevin W Moore
Kenneth Pennline
Paulo J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA937244B publication Critical patent/ZA937244B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA937244A 1992-10-01 1993-09-29 Use of IL-10 to prevent or treat insulin-dependentdiabetes mellitus ZA937244B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01

Publications (1)

Publication Number Publication Date
ZA937244B true ZA937244B (en) 1994-06-27

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937244A ZA937244B (en) 1992-10-01 1993-09-29 Use of IL-10 to prevent or treat insulin-dependentdiabetes mellitus

Country Status (24)

Country Link
EP (1) EP0662837B1 (sv)
JP (1) JP2739770B2 (sv)
KR (1) KR0166663B1 (sv)
CN (1) CN1093598A (sv)
AT (1) ATE180168T1 (sv)
AU (1) AU689448B2 (sv)
CA (1) CA2145863A1 (sv)
CZ (1) CZ286866B6 (sv)
DE (1) DE69325029T2 (sv)
DK (1) DK0662837T3 (sv)
ES (1) ES2131122T3 (sv)
FI (1) FI951511A (sv)
GR (1) GR3030269T3 (sv)
HK (1) HK1008812A1 (sv)
HU (1) HU217871B (sv)
IL (1) IL107153A (sv)
MX (1) MX9306043A (sv)
MY (1) MY111543A (sv)
NO (1) NO951240L (sv)
SG (1) SG48733A1 (sv)
SK (1) SK281806B6 (sv)
TW (1) TW336172B (sv)
WO (1) WO1994008606A1 (sv)
ZA (1) ZA937244B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0752879A4 (en) * 1994-04-08 1999-07-21 Brigham & Womens Hospital TREATMENT OF AUTOIMMUNE DISEASES WITH TOLERANCE INDUCING AGENTS AND / OR ORAL TH2-ENHANCING CYTOKINES
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
JPH11501506A (ja) * 1994-12-12 1999-02-09 ベス イスラエル デアコネス メディカル センター キメラ型サイトカインおよびその利用
WO1997005895A1 (en) * 1995-08-07 1997-02-20 Schering Corporation Treatment of ocular inflammatory conditions with interleukin-10
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US5939069A (en) 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
WO1999006059A2 (en) * 1997-07-30 1999-02-11 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
WO1999019301A1 (fr) * 1997-10-14 1999-04-22 Yoshitomi Pharmaceutical Industries, Ltd. Composes de piperazine et utilisation medicale desdits composes
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
EP2937088B1 (en) 2012-12-21 2020-11-18 Tokushima University Composition having tissue repairing activity and utilization thereof
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
WO2017181143A1 (en) 2016-04-15 2017-10-19 Generon (Shanghai) Corporation, Ltd. Use of il-22 in treating necrotizing enterocolitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
ES2131122T3 (es) 1999-07-16
AU689448B2 (en) 1998-04-02
TW336172B (en) 1998-07-11
AU5163593A (en) 1994-05-09
SG48733A1 (en) 1998-05-18
KR0166663B1 (en) 1999-01-15
CA2145863A1 (en) 1994-04-28
KR950703353A (ko) 1995-09-20
HU217871B (hu) 2000-04-28
SK281806B6 (sk) 2001-08-06
DE69325029T2 (de) 1999-10-07
IL107153A0 (en) 1993-12-28
MY111543A (en) 2000-08-30
IL107153A (en) 2000-07-16
NO951240D0 (no) 1995-03-30
FI951511A0 (sv) 1995-03-30
DK0662837T3 (da) 1999-11-08
CZ80495A3 (en) 1996-01-17
JPH07507567A (ja) 1995-08-24
ATE180168T1 (de) 1999-06-15
GR3030269T3 (en) 1999-08-31
FI951511A (sv) 1995-03-30
HU9500933D0 (en) 1995-05-29
JP2739770B2 (ja) 1998-04-15
CZ286866B6 (en) 2000-07-12
HUT71421A (en) 1995-11-28
EP0662837A1 (en) 1995-07-19
WO1994008606A1 (en) 1994-04-28
HK1008812A1 (en) 1999-05-21
NO951240L (no) 1995-05-30
MX9306043A (es) 1994-04-29
CN1093598A (zh) 1994-10-19
DE69325029D1 (de) 1999-06-24
EP0662837B1 (en) 1999-05-19
SK42395A3 (en) 1997-01-08

Similar Documents

Publication Publication Date Title
EP0686203A4 (en) COMPOUNDS AND METHODS RELATING TO THE DIAGNOSIS, TREATMENT AND PREVENTION OF CELL DEATH DISEASES
SG48733A1 (en) Use of il-10 to prevent or treat insulin-dependent diabetes mellitus
AU7545594A (en) Implantable device for the treatment of aedemas
AU8138687A (en) Agents for combating pests and plant treatment agents
PL274899A1 (en) Agent for fighting against or preventing aggression by harmful insects or microorganisms
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
AU4714393A (en) Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
EP0594410A3 (en) Treatment of rubber articles.
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
EP0630383A4 (en) METHODS OF TREATING DIABETES.
GB9323808D0 (en) Composition containing zinc for the treatment of skin disorders
EP0674707A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF LEUCOMA.
ZA931063B (en) Treatment of glaucoma.
HU9502623D0 (en) Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure
IL105285A0 (en) Compositions for the treatment of diabetes
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
ZA913920B (en) Therapeutic compound
ES8507552A1 (es) Un procedimiento para preparar 6-metilsulfonil-espiro-(croman-4,4'-imidazolidin)-2',5'-diona
EP0609335A4 (en) Methods for the treatment of hyperlipidemia using azaspiranes.
ZA931062B (en) Compositions for the treatment of glaucoma.
AR245225A1 (es) Composiciones para el tratamiento de cuero.
AU8488591A (en) Apparatus for treatment of vegetation
BG98001U (en) Medicament for the treatment of hyperkeratotic conditions of the skin
AU7715291A (en) Treatment of horses using ethylestrenol